Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
Maha Othman, Co-Chairman SSC on Disseminated intravascular coagulopathy at International Society on Thrombosis and Haemostasis, shared a post on LinkedIn:
“What an amazing day at CanVECTOR 2026 in Montreal!
A fantastic time filled with inspiring science, excellent talks, new collaborations, networking, and lots of fun!
Proud of our trainees from St. Lawrence College and Queen’s University for their contributions:
- Yousra Tera presenting her poster on Thromboelastography as an approach to improving VTE risk assessment in women with cancer under chemotherapy.
- Jordan Harry presenting her systematic review on the global incidence of VTE in patients with haematological malignancies.
I also thoroughly enjoyed an inspiring talk by a brilliant colleague and friend Dr. Kerstin de Witt on the future models of thrombosis medicine, and an oral abstract on establishing reference range for TEG 6 on healthy adults from our new and amazing collaborator Dr. Prism Shneider.
I was delighted to be invited to speak on such a complex and fascinating topic: ‘Immunothrombosis and thromboinflammation in Cancer: From Mechanisms to Clinical Impact’.
I enjoyed the discussion of whether their measurement of this pathology is helpful to improve risk of thrombosis in cancer patient.
Particularly proud of my trainee Yousra Tera moderating the session!
Equally enjoyable was facilitating the special trainee roundtable discussion around careers and how to build connections between clinical investigators and the laboratory in research.
Leaving Montreal with new ideas, promising collaborations, and great memories!
A big thank you to the CanVECTOR Research Network community for bringing everyone together.
Looking forward to what comes next!”
Other posts featuring Maha Othman on Hemostasis Today.
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden
-
Nov 13, 2026, 15:10Sally Mandour: Ringed Sideroblasts in Peripheral Blood
-
Nov 13, 2026, 14:58Lorena Arranz: The Power of Patient Engagement in Advancing MPN Research
-
Nov 13, 2026, 14:46Shehab Mohamed: SGLT2 Inhibitors in Anemia Management
-
Nov 13, 2026, 14:25Dino Mehic: Targeting TFPI in Unexplained Bleeding Disorders